As weight drops fast, cosmetic clinics see surge in ‘Ozempic face’ fixes
Summary
With the GLP-1 drug market expanding after the patent expiry of semaglutide in India, doctors expect demand to grow exponentially, and caution that unchecked us...
Original reporting
Open original sourceAFBytes is a read-only aggregator. Use the original source for full context and complete reporting.